OMA1

Last updated
OMA1
Identifiers
Aliases OMA1 , 2010001O09Rik, DAB1, MPRP-1, YKR087C, ZMPpeptidase, OMA1 zinc metallopeptidase, MPRP1
External IDs OMIM: 617081 MGI: 1914263 HomoloGene: 12070 GeneCards: OMA1
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_145243

NM_025909

RefSeq (protein)

NP_660286

NP_080185

Location (UCSC) Chr 1: 58.42 – 58.55 Mb Chr 4: 103.17 – 103.23 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Metalloendopeptidase OMA1, mitochondrial is an enzyme that in humans is encoded by the OMA1 gene. [5] [6] OMA1 is a Zn2+-dependent metalloendopeptidase in the inner membrane of mitochondria. The OMA1 acronym was derived from overlapping proteolytic activity with m-AAA protease 1. [6]

Contents

The OMA1 protease acts at the intersection of a mitochondrial quality control system and energy metabolism, whereby its activation correlates with outer membrane permeabilization and cytochrome c release in the context of apoptosis.

Mammalian OMA1 can cleave the inner-membrane shaping protein OPA1 and the signaling peptide DELE1 in a context-dependent manner. [7] [8] [9] [10]

Gene

The human OMA1 gene spans with 9 exons 66 kb of the reverse strand of the short arm of chromosome 1 (1p32.2-p32.1). OMA1 is conserved and homologues have been identified in model organisms, such as mice and yeast. Yet, no homologous have been found in C. elegans and drosophila . [11]

Structure

The human OMA1 protein comprises 524 amino acids. The nuclear encoded protein exhibits an amino-terminal mitochondrial import sequence, which is removed upon import giving rise to a 43.8 kDa mature protease. [12] OMA1 has a HEXXH Zn2+-binding motive and the MEROPS database classifies OMA1 as metalloendopeptidase of the M48C-family. [13] OMA1’s structure has not yet been resolved. Two controversial models describe OMA1 either as membrane-anchored protease [11] or as integral membrane protease. [14] Google's AlphaFold predictions are more aligned with the latter model, but have so far not provided a realistic 3D structure. [15] OMA1’s context-dependent regulation is not understood. The mammalian protein has an extended carboxy-terminus, which may be involved in its regulation. [16]

Function

OMA1’s function evolved over time with distinct substrates in invertebrates and mammals. [17] Initially described in yeast as "a novel component of the quality control system in the inner membrane of mitochondria," [6] mammalian OMA1 is responsible for stress-dependent OPA1 cleavage. [7] [8] Apoptotic stimuli, such as Bax and Bak, as well as other factors can trigger OMA1 activation and OPA1 processing, which are correlated with outer membrane permeabilization and cytochrome c release. [18] [19] The DELE1 protein is another OMA1 substrate, which is released upon cleavage into the cytosol, where it can activate the integrated stress response. [9] [10] OMA1 and the i-AAA protease share the OPA1 substrate and were suggested to regulate each other by reciprocal proteolytic hydrolysis. [20] [21] OMA1 functionally interacts with the eponymous m-AAA protease and other scaffold proteins in the inner membrane, such as the prohibitins PHB1 and PHB2. [22]

Clinical significance

OMA1 is not directly linked to a specific disease. 3 heterozygous coding sequence variants of uncertain significance were identified in the OMA1 gene in a screen of 190 individuals with Amyotrophic Lateral Sclerosis. [23] Whole exome sequencing of 1,000 individuals with heart failure revealed an association with the coding polymorphism rs17117699 (OMA1 p.Phe211Cys). [24] OMA1 may still have disease relevance through its substrates OPA1 and DELE1. Also certain misrouted PINK1 mutants pertaining to Parkinson's disease were found to be digested by OMA1. [25] Conditional OMA1 activation in neurons led to neurodegeneration with tau hyperphosphorylation in mice. [26] OMA1 knockout mice by contrast show mild energy-metabolic alterations without apparent impact on survival or lifespan. [27] OMA1 was also suggested to be relevant for cancer given OMA1’s energy-metabolic regulation and stress-dependent signaling. [28]

Related Research Articles

<span class="mw-page-title-main">Mitochondrial membrane transport protein</span>

Mitochondrial membrane transport proteins, also known as mitochondrial carrier proteins, are proteins which exist in the membranes of mitochondria. They serve to transport molecules and other factors, such as ions, into or out of the organelles. Mitochondria contain both an inner and outer membrane, separated by the inter-membrane space, or inner boundary membrane. The outer membrane is porous, whereas the inner membrane restricts the movement of all molecules. The two membranes also vary in membrane potential and pH. These factors play a role in the function of mitochondrial membrane transport proteins. There are 53 discovered human mitochondrial membrane transporters, with many others that are known to still need discovered.

<span class="mw-page-title-main">Caspase 2</span> Protein-coding gene in the species Homo sapiens

Caspase 2 also known as CASP2 is an enzyme that, in humans, is encoded by the CASP2 gene. CASP2 orthologs have been identified in nearly all mammals for which complete genome data are available. Unique orthologs are also present in birds, lizards, lissamphibians, and teleosts.

<span class="mw-page-title-main">MFN2</span> Protein-coding gene in the species Homo sapiens

Mitofusin-2 is a protein that in humans is encoded by the MFN2 gene. Mitofusins are GTPases embedded in the outer membrane of the mitochondria. In mammals MFN1 and MFN2 are essential for mitochondrial fusion. In addition to the mitofusins, OPA1 regulates inner mitochondrial membrane fusion, and DRP1 is responsible for mitochondrial fission.

<span class="mw-page-title-main">Dynamin-like 120 kDa protein</span> Protein-coding gene in the species Homo sapiens

Dynamin-like 120 kDa protein, mitochondrial is a protein that in humans is encoded by the OPA1 gene. This protein regulates mitochondrial fusion and cristae structure in the inner mitochondrial membrane (IMM) and contributes to ATP synthesis and apoptosis, and small, round mitochondria. Mutations in this gene have been implicated in dominant optic atrophy (DOA), leading to loss in vision, hearing, muscle contraction, and related dysfunctions.

<span class="mw-page-title-main">DNM1L</span> Protein-coding gene in humans

Dynamin-1-like protein is a GTPase that regulates mitochondrial fission. In humans, dynamin-1-like protein, which is typically referred to as dynamin-related protein 1 (Drp1), is encoded by the DNM1L gene and is part of the dynamin superfamily (DSP) family of proteins.

<span class="mw-page-title-main">LONP1</span> Human protein and coding gene

Lon protease homolog, mitochondrial is a protease, an enzyme that in humans is encoded by the LONP1 gene.

<span class="mw-page-title-main">PITRM1</span> Protein-coding gene in humans

Pitrilysin metallopeptidase 1 also known as presequence protease, mitochondrial (PreP) and metalloprotease 1 (MTP-1) is an enzyme that in humans is encoded by the PITRM1 gene. It is also sometimes called metalloprotease 1 (MP1).PreP facilitates proteostasis by utilizing an ~13300-A(3) catalytic chamber to degrade toxic peptides, including mitochondrial presequences and β-amyloid. Deficiency of PreP is found associated with Alzheimer's disease. Reduced levels of PreP via RNAi mediated knockdown have been shown to lead to defective maturation of the protein Frataxin.

<span class="mw-page-title-main">PMPCB</span> Protein-coding gene in humans

Mitochondrial-processing peptidase subunit beta is an enzyme that in humans is encoded by the PMPCB gene. This gene is a member of the peptidase M16 family and encodes a protein with a zinc-binding motif. This protein is located in the mitochondrial matrix and catalyzes the cleavage of the leader peptides of precursor proteins newly imported into the mitochondria, though it only functions as part of a heterodimeric complex.

<span class="mw-page-title-main">YME1L1</span> Protein-coding gene in the species Homo sapiens

ATP-dependent metalloprotease YME1L1 is an enzyme that in humans is encoded by the YME1L1 gene. YME1L1 belongs to the AAA family of ATPases and mainly functions in the maintenance of mitochondrial morphology. Mutations in this gene would cause infantile-onset mitochondriopathy.

<span class="mw-page-title-main">MARCH5</span> Protein-coding gene in the species Homo sapiens

E3 ubiquitin-protein ligase MARCH5, also known as membrane-associated ring finger (C3HC4) 5, is an enzyme that, in humans, is encoded by the MARCH5 gene. It is localized in the mitochondrial outer membrane and has four transmembrane domains.

<span class="mw-page-title-main">PARL</span> Protein-coding gene in the species Homo sapiens

Presenilins-associated rhomboid-like protein, mitochondrial (PSARL), also known as PINK1/PGAM5-associated rhomboid-like protease (PARL), is an inner mitochondrial membrane protein that in humans is encoded by the PARL gene on chromosome 3. It is a member of the rhomboid family of intramembrane serine proteases. This protein is involved in signal transduction and apoptosis, as well as neurodegenerative diseases and type 2 diabetes.

<span class="mw-page-title-main">ATP-dependent Clp protease proteolytic subunit</span> Protein-coding gene in the species Homo sapiens

ATP-dependent Clp protease proteolytic subunit (ClpP) is an enzyme that in humans is encoded by the CLPP gene. This protein is an essential component to form the protein complex of Clp protease.

<span class="mw-page-title-main">ADP/ATP translocase 4</span> Protein-coding gene in the species Homo sapiens

ADP/ATP translocase 4 (ANT4) is an enzyme that in humans is encoded by the SLC25A31 gene on chromosome 4. This enzyme inhibits apoptosis by catalyzing ADP/ATP exchange across the mitochondrial membranes and regulating membrane potential. In particular, ANT4 is essential to spermatogenesis, as it imports ATP into sperm mitochondria to support their development and survival. Outside this role, the SLC25AC31 gene has not been implicated in any human disease.

Mitophagy is the selective degradation of mitochondria by autophagy. It often occurs to defective mitochondria following damage or stress. The process of mitophagy was first described over a hundred years ago by Margaret Reed Lewis and Warren Harmon Lewis. Ashford and Porter used electron microscopy to observe mitochondrial fragments in liver lysosomes by 1962, and a 1977 report suggested that "mitochondria develop functional alterations which would activate autophagy." The term "mitophagy" was in use by 1998.

Mitochondrial biogenesis is the process by which cells increase mitochondrial numbers. It was first described by John Holloszy in the 1960s, when it was discovered that physical endurance training induced higher mitochondrial content levels, leading to greater glucose uptake by muscles. Mitochondrial biogenesis is activated by numerous different signals during times of cellular stress or in response to environmental stimuli, such as aerobic exercise.

<span class="mw-page-title-main">Rhomboid protease</span>

The rhomboid proteases are a family of enzymes that exist in almost all species. They are proteases: they cut the polypeptide chain of other proteins. This proteolytic cleavage is irreversible in cells, and an important type of cellular regulation. Although proteases are one of the earliest and best studied class of enzyme, rhomboids belong to a much more recently discovered type: the intramembrane proteases. What is unique about intramembrane proteases is that their active sites are buried in the lipid bilayer of cell membranes, and they cleave other transmembrane proteins within their transmembrane domains. About 30% of all proteins have transmembrane domains, and their regulated processing often has major biological consequences. Accordingly, rhomboids regulate many important cellular processes, and may be involved in a wide range of human diseases.

<span class="mw-page-title-main">Mitochondrial fission factor</span> Protein-coding gene in the species Homo sapiens

Mitochondrial fission factor (Mff) is a protein that in humans is encoded by the MFF gene. Its primary role is in controlling the division of mitochondria. Mitochondrial morphology changes by continuous fission in order to create interconnected network of mitochondria. This activity is crucial for normal function of mitochondria. Mff is anchored to the mitochondrial outer membrane through the C-terminal transmembrane domain, extruding the bulk of the N-terminal portion containing two short amino acid repeats in the N-terminal half and a coiled-coil domain just upstream of the transmembrane domain into the cytosol. It has also been shown to regulate peroxisome morphology.

Kiss-and-run fusion is a type of synaptic vesicle release where the vesicle opens and closes transiently. In this form of exocytosis, the vesicle docks and transiently fuses at the presynaptic membrane and releases its neurotransmitters across the synapse, after which the vesicle can then be reused.

<span class="mw-page-title-main">Mitochondrial fusion</span> Merging of two or more mitochondria within a cell to form a single compartment

Mitochondria are dynamic organelles with the ability to fuse and divide (fission), forming constantly changing tubular networks in most eukaryotic cells. These mitochondrial dynamics, first observed over a hundred years ago are important for the health of the cell, and defects in dynamics lead to genetic disorders. Through fusion, mitochondria can overcome the dangerous consequences of genetic malfunction. The process of mitochondrial fusion involves a variety of proteins that assist the cell throughout the series of events that form this process.

<span class="mw-page-title-main">ClpX</span> Mammalian protein found in Homo sapiens

ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial is an enzyme that in humans is encoded by the CLPX gene. This protein is a member of the family of AAA Proteins and is to form the protein complex of Clp protease.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000162600 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000035069 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Entrez Gene: OMA1 zinc metallopeptidase".
  6. 1 2 3 Kaser M, Kambacheld M, Kisters-Woike B, Langer T (November 2003). "Oma1, a novel membrane-bound metallopeptidase in mitochondria with activities overlapping with the m-AAA protease". The Journal of Biological Chemistry. 278 (47): 46414–23. doi: 10.1074/jbc.m305584200 . PMID   12963738.
  7. 1 2 Ehses S, Raschke I, Mancuso G, Bernacchia A, Geimer S, Tondera D, et al. (December 2009). "Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1". The Journal of Cell Biology. 187 (7): 1023–36. doi:10.1083/jcb.200906084. PMC   2806285 . PMID   20038678.
  8. 1 2 Head B, Griparic L, Amiri M, Gandre-Babbe S, van der Bliek AM (December 2009). "Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells". The Journal of Cell Biology. 187 (7): 959–66. doi:10.1083/jcb.200906083. PMC   2806274 . PMID   20038677.
  9. 1 2 Guo X, Aviles G, Liu Y, Tian R, Unger BA, Lin YT, et al. (March 2020). "Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway". Nature. 579 (7799): 427–432. Bibcode:2020Natur.579..427G. doi:10.1038/s41586-020-2078-2. PMC   7147832 . PMID   32132707.
  10. 1 2 Fessler E, Eckl EM, Schmitt S, Mancilla IA, Meyer-Bender MF, Hanf M, et al. (March 2020). "A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol". Nature. 579 (7799): 433–437. Bibcode:2020Natur.579..433F. doi:10.1038/s41586-020-2076-4. PMC   7116715 . PMID   32132706.
  11. 1 2 Levytskyy RM, Bohovych I, Khalimonchuk O (September 2017). "Metalloproteases of the Inner Mitochondrial Membrane". Biochemistry. 56 (36): 4737–4746. doi:10.1021/acs.biochem.7b00663. PMC   5792295 . PMID   28806058.
  12. Baker MJ, Lampe PA, Stojanovski D, Korwitz A, Anand R, Tatsuta T, Langer T (March 2014). "Stress-induced OMA1 activation and autocatalytic turnover regulate OPA1-dependent mitochondrial dynamics". The EMBO Journal. 33 (6): 578–93. doi:10.1002/embj.201386474. PMC   3989652 . PMID   24550258.
  13. "MEROPS - the Peptidase Database". www.ebi.ac.uk. Retrieved 2021-10-06.
  14. Alavi MV (February 2021). "OMA1-An integral membrane protease?". Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1869 (2): 140558. doi:10.1016/j.bbapap.2020.140558. PMC   7770061 . PMID   33130089.
  15. "AlphaFold Protein Structure Database". alphafold.ebi.ac.uk. Retrieved 2021-10-06.
  16. Zhang K, Li H, Song Z (May 2014). "Membrane depolarization activates the mitochondrial protease OMA1 by stimulating self-cleavage". EMBO Reports. 15 (5): 576–85. doi:10.1002/embr.201338240. PMC   4210089 . PMID   24719224.
  17. Duvezin-Caubet S, Koppen M, Wagener J, Zick M, Israel L, Bernacchia A, et al. (September 2007). "OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria". Molecular Biology of the Cell. 18 (9): 3582–90. doi:10.1091/mbc.e07-02-0164. PMC   1951777 . PMID   17615298.
  18. Jiang X, Jiang H, Shen Z, Wang X (October 2014). "Activation of mitochondrial protease OMA1 by Bax and Bak promotes cytochrome c release during apoptosis". Proceedings of the National Academy of Sciences of the United States of America. 111 (41): 14782–7. Bibcode:2014PNAS..11114782J. doi: 10.1073/pnas.1417253111 . PMC   4205663 . PMID   25275009.
  19. Richter U, Lahtinen T, Marttinen P, Suomi F, Battersby BJ (October 2015). "Quality control of mitochondrial protein synthesis is required for membrane integrity and cell fitness". The Journal of Cell Biology. 211 (2): 373–89. doi:10.1083/jcb.201504062. PMC   4621829 . PMID   26504172.
  20. Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, Langer T (March 2014). "The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission". The Journal of Cell Biology. 204 (6): 919–29. doi:10.1083/jcb.201308006. PMC   3998800 . PMID   24616225.
  21. Rainbolt TK, Lebeau J, Puchades C, Wiseman RL (March 2016). "Reciprocal Degradation of YME1L and OMA1 Adapts Mitochondrial Proteolytic Activity during Stress". Cell Reports. 14 (9): 2041–2049. doi:10.1016/j.celrep.2016.02.011. PMC   4785047 . PMID   26923599.
  22. Deshwal S, Fiedler KU, Langer T (June 2020). "Mitochondrial Proteases: Multifaceted Regulators of Mitochondrial Plasticity". Annual Review of Biochemistry. 89: 501–528. doi:10.1146/annurev-biochem-062917-012739. PMID   32075415. S2CID   211216115.
  23. Daoud H, Valdmanis PN, Gros-Louis F, Belzil V, Spiegelman D, Henrion E, et al. (May 2011). "Resequencing of 29 candidate genes in patients with familial and sporadic amyotrophic lateral sclerosis". Archives of Neurology. 68 (5): 587–93. doi: 10.1001/archneurol.2010.351 . PMID   21220648.
  24. Hu D, Li S, Hu S, Sun Y, Xiao L, Li C, et al. (June 2020). "A Common Missense Variant in OMA1 Associated with the Prognosis of Heart Failure". Cardiovascular Drugs and Therapy. 34 (3): 345–356. doi:10.1007/s10557-020-06960-8. PMID   32236861. S2CID   214715802.
  25. Sekine S, Wang C, Sideris DP, Bunker E, Zhang Z, Youle RJ (March 2019). "Reciprocal Roles of Tom7 and OMA1 during Mitochondrial Import and Activation of PINK1". Molecular Cell. 73 (5): 1028–1043.e5. doi: 10.1016/j.molcel.2019.01.002 . PMID   30733118. S2CID   73450413.
  26. Korwitz A, Merkwirth C, Richter-Dennerlein R, Tröder SE, Sprenger HG, Quirós PM, et al. (January 2016). "Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria". The Journal of Cell Biology. 212 (2): 157–66. doi:10.1083/jcb.201507022. PMC   4738383 . PMID   26783299.
  27. Quirós PM, Ramsay AJ, Sala D, Fernández-Vizarra E, Rodríguez F, Peinado JR, et al. (May 2012). "Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice". The EMBO Journal. 31 (9): 2117–33. doi:10.1038/emboj.2012.70. PMC   3343468 . PMID   22433842.
  28. Alavi MV (November 2019). "Targeted OMA1 therapies for cancer". International Journal of Cancer. 145 (9): 2330–2341. doi: 10.1002/ijc.32177 . PMID   30714136. S2CID   73438438.